Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 101.00
-1.00 (-0.98%)
Jul 30, 2026, 11:20 AM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 158.75 billion as of July 29, 2026. Its market cap has decreased by -20.66% in one year.
Market Cap
158.75B
Enterprise Value
153.86B
Revenue
38.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
101.00
ChartMarket Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 158.75B, an increase of 1,894.74%. That is a compound annual growth rate of 129.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 158.75B | -33.92% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 52.84B |
| Pell Bio-Med Technology | 51.96B |
| CHO Pharma | 23.86B |
| Sunmax Biotechnology | 20.59B |
| Oneness Biotech | 20.25B |
| TaiMed Biologics | 15.44B |
| Medigen Vaccine Biologics | 15.02B |
| Lumosa Therapeutics | 14.76B |